Solid Cancers: NILK-2401 Antibody Study

We are testing a new antibody treatment for solid cancers, both alone and with another cancer therapy. This study aims to find out how effective it may be for patients.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitari Vall D Hebron
Medical Oncology
Barcelona, Spain
Hospital Universitario Fundacion Jimenez Diaz
Oncology
Madrid, Spain
Clinica Universidad De Navarra
Oncology
Pamplona, Spain

Sponsor: NovImmune SA
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.